These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17690799)

  • 1. Mechanisms of action in integrated cognitive-behavioral treatment versus twelve-step facilitation for substance-dependent adults with comorbid major depression.
    Glasner-Edwards S; Tate SR; McQuaid JR; Cummins K; Granholm E; Brown SA
    J Stud Alcohol Drugs; 2007 Sep; 68(5):663-72. PubMed ID: 17690799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological functioning and outcomes of treatment for co-occurring depression and substance use disorders.
    Granholm E; Tate SR; Link PC; Lydecker KP; Cummins KM; McQuaid J; Shriver C; Brown SA
    Am J Drug Alcohol Abuse; 2011 Jul; 37(4):240-9. PubMed ID: 21517712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 12-step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model.
    Worley MJ; Tate SR; McQuaid JR; Granholm EL; Brown SA
    Subst Abus; 2013; 34(1):43-50. PubMed ID: 23327503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated cognitive behavioral therapy versus twelve-step facilitation therapy for substance-dependent adults with depressive disorders.
    Brown SA; Glasner-Edwards SV; Tate SR; McQuaid JR; Chalekian J; Granholm E
    J Psychoactive Drugs; 2006 Dec; 38(4):449-60. PubMed ID: 17373561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Cognitive Behavioral Therapy Versus Cognitive Processing Therapy for Adults With Depression, Substance Use Disorder, and Trauma.
    Haller M; Norman SB; Cummins K; Trim RS; Xu X; Cui R; Allard CB; Brown SA; Tate SR
    J Subst Abuse Treat; 2016 Mar; 62():38-48. PubMed ID: 26718130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediational relations between 12-Step attendance, depression and substance use in patients with comorbid substance dependence and major depression.
    Worley MJ; Tate SR; Brown SA
    Addiction; 2012 Nov; 107(11):1974-83. PubMed ID: 22578037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of an integrated treatment for depression and substance use disorders.
    Lydecker KP; Tate SR; Cummins KM; McQuaid J; Granholm E; Brown SA
    Psychol Addict Behav; 2010 Sep; 24(3):453-65. PubMed ID: 20853931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does initial treatment focus influence outcomes for depressed substance abusers?
    Drapkin ML; Tate SR; McQuaid JR; Brown SA
    J Subst Abuse Treat; 2008 Oct; 35(3):343-50. PubMed ID: 18295436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttraumatic stress disorder's role in integrated substance dependence and depression treatment outcomes.
    Norman SB; Tate SR; Wilkins KC; Cummins K; Brown SA
    J Subst Abuse Treat; 2010 Jun; 38(4):346-55. PubMed ID: 20363091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people.
    Hides L; Carroll S; Catania L; Cotton SM; Baker A; Scaffidi A; Lubman DI
    J Affect Disord; 2010 Feb; 121(1-2):169-74. PubMed ID: 19604584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial.
    Worley MJ; Trim RS; Roesch SC; Mrnak-Meyer J; Tate SR; Brown SA
    J Subst Abuse Treat; 2012 Oct; 43(3):291-302. PubMed ID: 22406052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Process and outcome changes with relapse prevention versus 12-Step aftercare programs for substance abusers.
    Brown TG; Seraganian P; Tremblay J; Annis H
    Addiction; 2002 Jun; 97(6):677-89. PubMed ID: 12084137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internet Cognitive-Behavioral Therapy for Depression in Older Adults With Knee Osteoarthritis: A Randomized Controlled Trial.
    O'moore KA; Newby JM; Andrews G; Hunter DJ; Bennell K; Smith J; Williams AD
    Arthritis Care Res (Hoboken); 2018 Jan; 70(1):61-70. PubMed ID: 28426917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coping strategies related to treatment in substance use disorder patients with and without comorbid depression.
    Adan A; Antúnez JM; Navarro JF
    Psychiatry Res; 2017 May; 251():325-332. PubMed ID: 28237911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of treatment retention for substance-dependent adults with co-occurring depression.
    Tate SR; Mrnak-Meyer J; Shriver CL; Atkinson JH; Robinson SK; Brown SA
    Am J Addict; 2011; 20(4):357-65. PubMed ID: 21679267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot randomized clinical trial testing integrated 12-Step facilitation (iTSF) treatment for adolescent substance use disorder.
    Kelly JF; Kaminer Y; Kahler CW; Hoeppner B; Yeterian J; Cristello JV; Timko C
    Addiction; 2017 Dec; 112(12):2155-2166. PubMed ID: 28742932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining changes in negative mood regulation expectancies, posttraumatic stress disorder, depression, and substance use following integrated cognitive-behavioral therapy.
    Siegel EY; Haller M; Cui R; Trim RS; Tate SR; Norman SB
    Subst Abus; 2017; 38(4):468-472. PubMed ID: 28632462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specialized 12-step programs and 12-step facilitation for the dually diagnosed.
    Bogenschutz MP
    Community Ment Health J; 2005 Feb; 41(1):7-20. PubMed ID: 15932050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders.
    Back SE; McCauley JL; Korte KJ; Gros DF; Leavitt V; Gray KM; Hamner MB; DeSantis SM; Malcolm R; Brady KT; Kalivas PW
    J Clin Psychiatry; 2016 Nov; 77(11):e1439-e1446. PubMed ID: 27736051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Service utilization during and after outpatient treatment for comorbid substance use disorder and depression.
    Worley MJ; Trim RS; Tate SR; Hall JE; Brown SA
    J Subst Abuse Treat; 2010 Sep; 39(2):124-31. PubMed ID: 20598832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.